When Dawn Steiner awoke one morning with joint pain so severe she couldn't even lift her arms, she knew something was wrong.

European researchers unveil digital tools and explainable AI that personalize psoriatic arthritis care, enabling early ...

An analysis of key drug trials for psoriatic arthritis shows geographic disparities and racial gaps; most participants have ...

Clinical improvements were achieved and maintained for up to 3 years among bDMARD-naïve patients with PsA who received bimekizumab.

EULAR - The European Alliance of Associations for Rheumatology - recommends a treat-to-target approach, and suggests more ...

Alongside the data in PsA, UCB will present at EULAR new results demonstrating that Bimzelx delivered sustained clinical ...